A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
By
Drake Mellott,
Chien-Te Tseng,
Aleksandra Drelich,
Pavla Fajtova,
Bala C Chenna,
Demetrios Kostomiris,
Jason C Hsu,
Jiyun Zhu,
Zane Taylor,
Vivian Tat,
Ardala Katzfuss,
Linfeng Li,
Miriam A Giardini,
Danielle Skinner,
Ken Hirata,
Sungjun Beck,
Aaron F Carlin,
Alex E. Clark,
Laura Berreta,
Daniel Maneval,
Felix Frueh,
Brett L Hurst,
Hong Wang,
Klaudia I Kocurek,
Frank M Raushel,
Anthony O'Donoghue,
Jair L. Siqueira-Neto,
Thomas D Meek,
James H. McKerrow
Posted 24 Oct 2020
bioRxiv DOI: 10.1101/2020.10.23.347534
K777 is a di-peptide analog that contains an electrophilic vinyl-sulfone moiety and is a potent, covalent inactivator of cathepsins. Vero E6, HeLa/ACE2, Caco-2, A549/ACE2, and Calu-3, cells were exposed to SARS-CoV-2, and then treated with K777. K777 reduced viral infectivity with EC50 values of inhibition of viral infection of: 74 nM for Vero E6, <80 nM for A549/ACE2, and 4 nM for HeLa/ACE2 cells. In contrast, Calu-3 and Caco-2 cells had EC50 values in the low micromolar range. No toxicity of K777 was observed for any of the host cells at 10-100 μM inhibitor. K777 did not inhibit activity of the papain-like cysteine protease and 3CL cysteine protease, encoded by SARS-CoV-2 at concentrations of ≤ 100 μM. These results suggested that K777 exerts its potent anti-viral activity by inactivation of mammalian cysteine proteases which are essential to viral infectivity. Using a propargyl derivative of K777 as an activity-based probe, K777 selectively targeted cathepsin B and cathepsin L in Vero E6 cells. However only cathepsin L cleaved the SARS-CoV-2 spike protein and K777 blocked this proteolysis. The site of spike protein cleavage by cathepsin L was in the S1 domain of SARS-CoV-2 , differing from the cleavage site observed in the SARS CoV-1 spike protein. These data support the hypothesis that the antiviral activity of K777 is mediated through inhibition of the activity of host cathepsin L and subsequent loss of viral spike protein processing. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 1,673 times
- Download rankings, all-time:
- Site-wide: 14,940
- In biochemistry: 312
- Year to date:
- Site-wide: 34,445
- Since beginning of last month:
- Site-wide: 21,414
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!